TenGen Biomedical Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $597K

  • Investors
  • 2

TenGen Biomedical General Information

Description

Developer of vaccine candidates designed to prevent viral infectious diseases and cancer. The company's products include vertebrate-specific replication-defective viruses and virus-like particle (VLP)-based technologies for the development of vaccines against the Zika virus, dengue virus, and other viral diseases, enabling researchers and healthcare providers to advance vaccine development and disease prevention.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 7220 Grubby Thicket Way
  • Bethesda, MD 20817-1510
  • United States
+1 (202)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • 7220 Grubby Thicket Way
  • Bethesda, MD 20817-1510
  • United States
+1 (202)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TenGen Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 01-Jan-2022 $597K Completed Startup
4. Accelerator/Incubator 01-Feb-2021 Completed Startup
3. Grant 01-Aug-2017 Completed Startup
2. Grant 01-Aug-2017 $652K Completed Startup
1. Grant 01-Jan-2006 $499K Completed Startup
To view TenGen Biomedical’s complete valuation and funding history, request access »

TenGen Biomedical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of vaccine candidates designed to prevent viral infectious diseases and cancer. The company's products include
Drug Discovery
Bethesda, MD

South San Francisco, CA
 

Rahway, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TenGen Biomedical Competitors (12)

One of TenGen Biomedical’s 12 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genentech Formerly VC-backed South San Francisco, CA
Merck & Co. Corporation Rahway, NJ
Ability Pharma Private Equity-Backed Cerdanyola, Spain
Gilead Formerly VC-backed Foster City, CA
Ona Therapeutics Venture Capital-Backed Barcelona, Spain
You’re viewing 5 of 12 competitors. Get the full list »

TenGen Biomedical Patents

TenGen Biomedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2023145738-A Mammal-specific growth defective arbovirus Pending 11-Sep-2017
EP-3681522-A1 Mammal-specific growth-defective arbovirus Pending 11-Sep-2017
EP-3681522-A4 Mammal-specific growth-defective arbovirus Pending 11-Sep-2017
US-12098393-B2 Mammal-specific growth-defective arbovirus Active 11-Sep-2017
WO-2019051445-A1 Mammal-specific growth-defective arbovirus Inactive 11-Sep-2017 C12N7/00
To view TenGen Biomedical’s complete patent history, request access »

TenGen Biomedical Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
U.S. Department of Health and Human Services Government
To view TenGen Biomedical’s complete investors history, request access »

TenGen Biomedical FAQs

  • When was TenGen Biomedical founded?

    TenGen Biomedical was founded in 2000.

  • Where is TenGen Biomedical headquartered?

    TenGen Biomedical is headquartered in Bethesda, MD.

  • What industry is TenGen Biomedical in?

    TenGen Biomedical’s primary industry is Drug Discovery.

  • Is TenGen Biomedical a private or public company?

    TenGen Biomedical is a Private company.

  • What is TenGen Biomedical’s current revenue?

    The current revenue for TenGen Biomedical is .

  • How much funding has TenGen Biomedical raised over time?

    TenGen Biomedical has raised $3M.

  • Who are TenGen Biomedical’s investors?

    National Institutes of Health and U.S. Department of Health and Human Services have invested in TenGen Biomedical.

  • Who are TenGen Biomedical’s competitors?

    Genentech, Merck & Co., Ability Pharma, Gilead, and Ona Therapeutics are some of the 12 competitors of TenGen Biomedical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process